Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects

E-ISSN： 1744-7631|7|3|385-397

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.7, Iss.3, 2003-06, pp. : 385-397

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Matrix metalloproteinase inhibitors and cancer

By Lauer-Fields J.L. Fields G.B.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. : 1873-1884

Informa Healthcare

Access to resources Recommend Favorite

Selective Matrix Metalloproteinase Inhibitors for Cancer

Current Medicinal Chemistry, Vol. 16, Iss. 29, 2009-10 ,pp. : 3805-3827

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Non-Cytotoxic Therapy in Ovarian Cancer: Current Status and Future Prospects

By Martin Lainie Schilder Russell J.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 9, 2006-10 ,pp. : 955-966

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Matrix Metalloproteinase Inhibitors for Cancer Therapy: Are Reports of Their Death Exaggerated?

Pharmaceutical Innovation, Vol. 11, Iss. 5, 2002-08 ,pp. : 17-20

Adis International

Access to resources Recommend Favorite

Cyclooxygenase inhibitors - current status and future prospects

By Dannhardt G. Kiefer W.

European Journal of Medicinal Chemistry, Vol. 36, Iss. 2, 2001-02 ,pp. : 109-126

Elsevier

Access to resources Recommend Favorite